Newsletter | January 8, 2024

01.08.24 -- Understanding Big Pharma Incubators

NEW PODCAST EPISODE

CDMO Collab With Scorpius BioManufacturing's Steve Lavezoli + Fina Biosolutions' Dr. Andrew Lees

Fina Biosolutions' Dr. Andrew Lees recently signed on with Scorpius BioManufacturing to support his company's growth plan. On the Business of Biotech, Lees sits down with Scorpius VP of commercial operations Steve Lavezoli for a frank conversation on the ups, downs, and expectations of a biotech + CDMO relationship. If you're considering signing on with an outsourced manufacturing partner, or thinking about making a switch, you won't want to miss this episode.

FEATURED ARTICLES

Evolving Business Models: Pharmaceutical Incubators

Big Pharma incubators offer unique funding and innovation opportunities for emerging biopharma companies and strong sources of external innovation for incubator host organizations.

CEO Q&A: David Younger, Ph.D.

Life Science Leader catches up with David Younger, cofounder and CEO of A-Alpha Bio, about the promise of molecular glues, the challenges of standing up a new company, and collaborating with Big Pharma.

SPONSOR

Join The Advancing RNA Community

Introducing Advancing RNA, an online community designed to be a forum and resource for professionals working on RNA-based therapeutics to better understand the challenges that confront them in areas like analytical/quality, manufacturing, formulation, outsourcing, clinical research, and supply chain/logistics. Sign up for the Advancing RNA newsletter, delivered to your inbox weekly.

INDUSTRY INSIGHTS

The Value Of Spent Media Analytics For Optimizing Cell Culture Performance

Explore how valuable insights into the status of cells in culture from the analysis of spent media can support more productive processing as well as medium formulation or culture parameter optimization.

Outsourcing Vendor Red Flag #2: Layers Of Oversight And Process

Depth of management typically is less about ensuring your trial progresses smoothly and more about hiding the CRO’s deficiencies or appeasing its own stakeholders.

CONTRIBUTE TO LIFE SCIENCE LEADER

Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director. 

Connect With Life Science Leader: